The ASCO Annual Meeting enters its second year in a virtual setting June 4-8, 2021, to ensure the safety and health of attendees while delivering groundbreaking science in oncology and timely information on clinical application and treatment new scientific data to the oncology community.

 

ASCO’s robust scientific and education meeting platform will provide attendees with live and on-demand access to top caliber scientific research presentations and slides. The online meeting experience will also offer opportunities to engage with and learn from oncology thought leaders from around the world, including interactivity and live question and answer in key sessions.

 

Expected pivotal trials: Keep an Eye Out For…

 

Updated results of the selective Bruton tyrosine kinase (BTK) inhibitor TG-1701, as monotherapy and in combination with ublituximab and umbralisib (U2) in patients (pts) with B-cell malignancies. (Abstract 7525)

 

Subcutaneous epcoritamab in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: Safety profile and antitumor activity. (Abstract 7518)

 

Copanlisib + rituximab versus rituximab + placebo in patients with relapsed follicular (FL) or marginal zone lymphoma (MZL): Subset analysis from the phase III CHRONOS-3 trial
(Abstract 7510)

 

Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study. (Abstract 7545)

 

NVG-111, a novel ROR1xCD3 bispecific antibody for non-Hodgkin lymphoma. (Abstract 7549)

 

And many more!

 

Registration

 

Registration for the Meeting is open and includes access all Education and Scientific Sessions, Poster Sessions, Online Exhibits, 2021 ASCO Annual Meeting Videos and Slides, Annual Meeting Proceedings, and ASCO Educational Bookas well as access to an online platform with interactive tools and Q&A.

 

Access to Content

 

Content will be delivered in two formats: on-demand and through a scheduled broadcast. The on-demand content will be comprised of 175 sessions—formats include Oral Abstract Sessions, Poster Sessions, Poster Discussion Sessions, and track-specific Clinical Science Symposia—and will be available on June 4 at 9:00 AM EST.

 

The scheduled broadcast will include 48 high-impact sessions with real-time engagement, live Q&A, and unparalleled learning; these sessions will begin on June 4 at 11:00 AM EST. Sessions will be available on-demand 2 hours after airing. Search the Digital Program and the Broadcast Schedule to plan your meeting experience.

 

For more information, visit: ASCO 2021 Annual Meeting